Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12) - 524125

World Biggest Tenders Source

This tender with title Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12) - 524125 has been published on Bidding Source portal dated 04 Aug 2026 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12) - 524125

Tender Type :

Invitation for Bids

Reference No. :

524125

Country :

Germany

Publish Date :

4 Aug 2026

Closing Date :

30 Sep 2028

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Agreement pursuant to Section 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the medicinal product Epclusa with the active ingredient combination Sofosbuvir/Velpatasvir - 520789 Germany Awarded - Supply of contrast agents to radiologists contracted with the KV Westfalen-Lippe and the KV Nordrhein (specialty lots A and E) - 521473 Germany RV Pharmaceutical Supply Hospital Pharmacy Kassel Prison I - 516894 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for various active ingredients/combinations, with the possibility of concluding such agreements at any time within the framework of the so-called Open House procedure. - 512015 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (open-house procedure) for pharmaceuticals - 509781 Germany Pharmaceutical products – Medicines containing the active ingredient entecavir (ATC: J05AF10 - in the dosage form of film-coated tablets) - 512862 Germany Pharmaceutical products – Medicines containing the active ingredient natalizumab (ATC: L04AG03) - 513599 Germany Pharmaceutical products – Medicines containing the active ingredients vilanterol and umeclidinium bromide (ATC: R03AL03) - 513665 Germany Pharmaceutical products – Medicines containing the active ingredient atomoxetine (ATC: N06BA09 - in the dosage form of hard capsules) - 514272 Germany Pharmaceutical products – Medicines containing the active ingredient nebivolol (ATC: C07AB12) - 514823 Germany

Conclusion not excluding drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by way of an open-house model for the active ingredient trientine (ATC code according to WHO: A16AX12) - 524125

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com